These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 17961866

  • 1. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
    Humbert M.
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S273-6. PubMed ID: 17961866
    [No Abstract] [Full Text] [Related]

  • 2. Observational trials in pulmonary arterial hypertension: low scientific evidence but high clinical value.
    Hoeper MM.
    Eur Respir J; 2007 Mar; 29(3):432-4. PubMed ID: 17329488
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Pulmonary arterial hypertension and systemic sclerosis].
    Launay D, Humbert M, Hachulla E.
    Presse Med; 2006 Dec; 35(12 Pt 2):1929-37. PubMed ID: 17159719
    [Abstract] [Full Text] [Related]

  • 5. Sildenafil in the treatment of pulmonary hypertension.
    Barnett CF, Machado RF.
    Vasc Health Risk Manag; 2006 Dec; 2(4):411-22. PubMed ID: 17323595
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sildenafil for enhanced performance at high altitude?
    Rubin LJ, Naeije R.
    Ann Intern Med; 2004 Aug 03; 141(3):233-5. PubMed ID: 15289224
    [No Abstract] [Full Text] [Related]

  • 9. An evidence-based approach to the management of pulmonary arterial hypertension.
    Archer SL, Michelakis ED.
    Curr Opin Cardiol; 2006 Jul 03; 21(4):385-92. PubMed ID: 16755209
    [Abstract] [Full Text] [Related]

  • 10. Summaries for patients. Sildenafil increases exercise capacity in low-oxygen settings.
    Ann Intern Med; 2004 Aug 03; 141(3):I12. PubMed ID: 15289233
    [No Abstract] [Full Text] [Related]

  • 11. Sildenafil citrate therapy for pulmonary arterial hypertension.
    Kuschner WG.
    N Engl J Med; 2006 Mar 09; 354(10):1091-3; author reply 1091-3. PubMed ID: 16528810
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of type-5 phosphodiesterase: promising therapy for pulmonary hypertension.
    Watanabe H.
    Intern Med; 2004 Oct 09; 43(10):891-3. PubMed ID: 15575233
    [No Abstract] [Full Text] [Related]

  • 13. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
    Johnson RF, Loyd JE, Mullican AL, Fink CA, Robbins IM.
    J Heart Lung Transplant; 2007 Apr 09; 26(4):363-9. PubMed ID: 17403478
    [Abstract] [Full Text] [Related]

  • 14. Sildenafil for pulmonary hypertension in ARDS: a new pleasant effect?
    Blanch L, Albaiceta GM.
    Intensive Care Med; 2010 May 09; 36(5):729-31. PubMed ID: 20130829
    [No Abstract] [Full Text] [Related]

  • 15. Pulmonary hypertension in older children: new approaches and therapies.
    Abman SH.
    Paediatr Respir Rev; 2006 May 09; 7 Suppl 1():S177-9. PubMed ID: 16798555
    [No Abstract] [Full Text] [Related]

  • 16. Sildenafil citrate therapy for pulmonary arterial hypertension.
    Izbicki G, Rosengarten D, Picard E.
    N Engl J Med; 2006 Mar 09; 354(10):1091-3; author reply 1091-3. PubMed ID: 16528809
    [No Abstract] [Full Text] [Related]

  • 17. Sildenafil in neonatal pulmonary hypertension due to impaired alveolarisation and plexiform pulmonary arteriopathy.
    Chaudhari M, Vogel M, Wright C, Smith J, Haworth SG.
    Arch Dis Child Fetal Neonatal Ed; 2005 Nov 09; 90(6):F527-8. PubMed ID: 16244212
    [Abstract] [Full Text] [Related]

  • 18. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension].
    Kayikçioğlu M, Can LH, Payzin S, Kültürsay H, Soydan I.
    Anadolu Kardiyol Derg; 2002 Sep 09; 2(3):262-4. PubMed ID: 12223337
    [No Abstract] [Full Text] [Related]

  • 19. Long-term results after addition of sildenafil in idiopathic PAH patients on bosentan.
    Minai OA, Arroliga AC.
    South Med J; 2006 Aug 09; 99(8):880-3. PubMed ID: 16929886
    [Abstract] [Full Text] [Related]

  • 20. Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion?
    Brancaccio G, Toscano A, Bevilacqua M, Di Chiara L, Parisi F.
    Pediatr Transplant; 2007 Feb 09; 11(1):110-2. PubMed ID: 17239133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.